Streetbeat News

Stock Prices

JFBR

MESO

PIK

Mesoblast Limited's shares surged by 13.4% after announcing FDA support for an accelerated approval pathway for rexlemestrocel-L. Other stocks also saw significant movements, with Kidpik Corp. leading the gainers with a 238% increase following a reverse stock split announcement. On the losers' side, Jeffs' Brands Ltd dropped by 45.2%. The market movements were influenced by various factors including FDA approvals, strategic plans, financial results expectations, and investment proposals.

Portfolio Pulse from Avi Kapoor

March 11, 2024 | 5:41 pm

FANH

KNSL

MRAI

ROOT

In Monday's intraday session, several insurance stocks experienced significant movements. Marpai, Fanhua, Huize Holding, Tian Ruixiang Holdings, Oxbridge Re Holdings, and MBIA were among the gainers, with increases ranging from 3.52% to 22.85%. Conversely, Root, Maiden Holdings, Cheche Group, Crawford, Kinsale Capital Group, and Goosehead Insurance were the losers, with decreases ranging from 2.93% to 4.09%.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 5:40 pm

DIA

EQT

META

MRNA

MRVL

QQQ

SPY

Wall Street experienced a slight decline as investors awaited February's inflation report. Treasury yields rose, indicating expectations of a less dovish Fed stance. Gold paused its rally, while Bitcoin surpassed $72,000 amid relaxed U.K. regulations for ETPs. The SPDR S&P 500 ETF Trust, SPDR Dow Jones Industrial Average ETF, and Invesco QQQ Trust saw minor losses. Meta Platforms and Marvell Technology faced significant drops, while Moderna surged. EQT Corp announced a cost-reduction plan amidst inheriting substantial debt.

Portfolio Pulse from Piero Cingari

March 11, 2024 | 5:37 pm

HSBC

HSBC Holdings Plc is expanding its U.S. commercial banking sector by planning to recruit 50 more bankers to focus on lending to startup companies in the technology and healthcare sectors. This move comes after hiring about 40 people from Silicon Valley Bank, aiming to fill a market void. HSBC's innovation banking business, with around 60 employees, has already signed up 250 companies, closing 35 lending deals. Despite this expansion, HSBC reported a revenue decline of 11% in the fourth quarter of FY23.

Portfolio Pulse from Lekha Gupta

March 11, 2024 | 5:35 pm

ARCC

BAC

COIN

JPM

ROOT

SOFI

WFC

Today's session highlighted significant options activity in the Financials sector, with notable movements in stocks like SOFI, C, COIN, BAC, JPM, ARCC, WFC, MS, NU, and ROOT. The activity ranged from bullish to bearish sentiments, with various expiration dates and strike prices. This options activity could indicate upcoming trading opportunities based on the whales' movements.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 5:35 pm

ABNB

AMZN

BABA

CHWY

CPNG

LEN

LVS

RIVN

TSLA

Today's session highlighted significant whale activity in the options market for 10 consumer discretionary stocks, indicating potential trading opportunities. The activity involved both call and put options with varying sentiments across stocks like TSLA, RIVN, BABA, and others. Notably, bearish sentiment dominated call options, while both bullish and neutral sentiments were observed in put and call trades. This activity could signal market expectations and potential shifts in stock prices.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 5:35 pm

AMD

ARM

MARA

NOW

NVDA

SMCI

SNOW

TEAM

TSM

Today's session highlighted significant whale activity in the Information Technology sector, focusing on options trading for stocks like AMD, NVDA, SMCI, TSM, NOW, ZM, TEAM, ARM, SNOW, and MARA. The trades varied in sentiment, with some showing bullish while others bearish outlooks, across various expiration dates and strike prices. Notably, ARM's put option trade with bullish sentiment involved a substantial total trade price of $1.0 million.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 5:35 pm

NVO

Novo Nordisk A/S (NYSE:NVO) is addressing patient harm caused by counterfeit versions of its diabetes drug, Ozempic, identified in 16 countries. CEO Lars Fruergaard Jorgensen emphasized the company's serious approach to the issue, collaborating with authorities worldwide. The demand for Novo's drugs, including weight loss-promoting ones, has led to a rise in counterfeit incidents. The FDA is investigating, and Novo Nordisk's Wegovy recently received FDA approval for expanded use. NVO shares dropped 1.01% to $131.72.

Portfolio Pulse from Vandana Singh

March 11, 2024 | 5:31 pm

BALY

BNED

PBPB

In Monday's intraday session, notable movements were observed in the consumer discretionary sector. Ballys, Smart Share Glb, Qurate Retail, Niu Techs, and NWTN were among the gainers with significant increases in their stock prices. Conversely, Jeffs Brands, China Liberal Education, Barnes & Noble Education, Singing Machine Co, and Potbelly experienced notable declines. The movements reflect varying market capitalizations and recent company performances, including Potbelly's Q4 earnings release.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 5:31 pm

LTRN

RGC

In Monday's intraday session, several healthcare stocks experienced significant movements. Regencell Bioscience led the gainers with a 130.9% increase, while Lantern Pharma topped the losers with a 22.8% decline. The movements reflect varying market capitalizations and investor reactions to company-specific news or broader sector trends.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 5:31 pm